Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients.
Kannan M, Sathiyarajeswaran P, Sasikumar D, Geetha A, Mohanapriya M, Vinod NP, Manickam P, Kanakavalli K, Parthibhan P, Pitchiah Kumar M, Kannan R, Sivaraman G. Kannan M, et al. Among authors: pitchiah kumar m. J Ayurveda Integr Med. 2022 Jul-Sep;13(3):100589. doi: 10.1016/j.jaim.2022.100589. Epub 2022 May 23. J Ayurveda Integr Med. 2022. PMID: 35634543 Free PMC article.
The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial.
Natarajan S, Anbarasi C, Sathiyarajeswaran P, Manickam P, Geetha S, Kathiravan R, Prathiba P, Pitchiahkumar M, Parthiban P, Kanakavalli K, Balaji P. Natarajan S, et al. Trials. 2020 Oct 27;21(1):892. doi: 10.1186/s13063-020-04823-z. Trials. 2020. PMID: 33109252 Free PMC article.
Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India.
Natarajan S, Anbarasi C, Sathiyarajeswaran P, Manickam P, Geetha S, Kathiravan R, Prathiba P, Pitchiahkumar M, Parthiban P, Kanakavalli K, Balaji P. Natarajan S, et al. Trials. 2021 Sep 15;22(1):623. doi: 10.1186/s13063-021-05583-0. Trials. 2021. PMID: 34526104 Free PMC article. Clinical Trial.